Skip to main content

Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Ensayo clínico Fase I/II para evaluar la seguridad y eficacia de la movilización y colecta de células CD34+ tras tratamiento con plerixafor y filgrastim en pacientes con Anemia de Fanconi para su posterior uso en ensayos de terapia génica

IP: Maria Cristina Díaz de Heredia Rubio
Collaborators: Josep Sánchez de Toledo Codina, Raquel Hladun Alvaro
Funding agency: Ministerio Sanidad
Funding: 437580
Reference: EC11-559
Duration: 01/01/2012 - 30/06/2018

Related news

Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.

La iniciativa "Sin Piedad" explica la història d'en David, un nen que s'està tractant d'un càncer pediàtric, un exemple d'actitud lluitadora davant la malaltia.

The money will allow research into paediatric nervous system tumours and childhood sarcomas to continue, with the aim of improving children's chances of survival and reducing the side effects of treatment.

Related professionals

Maria Jose Muñoz Blanco

Maria Jose Muñoz Blanco

Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Rosario Pardo  Diaz

Rosario Pardo Diaz

Research technician
Diabetes and Metabolism
Read more
Eduard Albuixech Ginesta

Eduard Albuixech Ginesta

Molecular Medical Imaging
Read more
Isabel Ramos Soriano

Isabel Ramos Soriano

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.